Doubt about the feasibility of preemptive genotyping

Clin Pharmacol Ther. 2013 Mar;93(3):233. doi: 10.1038/clpt.2012.191. Epub 2012 Dec 12.

Authors

B C P Koch, R H N van Schaik, T van Gelder, R H J Mathijssen; Rotterdam Clinical Pharmacology-Pharmacogenetics Group (RCPPG)

PMID: 23232547
DOI: 10.1038/clpt.2012.191

No abstract available

Publication types

Letter
Comment

MeSH terms

Drug-Related Side Effects and Adverse Reactions* / genetics*
Female
Humans
Male
Patient Safety*
Pharmacogenetics / methods*